The week in review
A lot can happen in just one week in Australia’s pharmacy sector… This week, AHPRA released its annual report and we got a look at the notification figures: only 6% …
Opioid deaths nearly double
More hospitalisations are caused by side effects of intended use of licit opioids, than from illicit use or misuse Harms highlighted in a new report underline the pressing need for …
Naloxone products chemically stable well past expiration date: study
Extended shelf-life has potential for stockpiles and communities, say US researchers A widely used naloxone nasal spray and naloxone injection, which are administered to prevent opioid overdose deaths, have been …
7,276 notifications and counting
From 2017-18, AHPRA received more notifications than in any other year and medication issues comprised 12.6% –but only 6% of notifications were about pharmacists For the year to 30 June 2018, …
Clinical tips: skin cancer
Louis Roller takes an in-depth look at skin cancer Approximately two in three Australians will be diagnosed with skin cancer by the time they are 70, with more than 750,000 …
Getting your ads right
AHPRA plans to run a pilot audit to check health practitioner compliance with advertising requirements in early 2019 Random audits of advertising compliance will advance a risk-based approach to enforcing …
‘We cannot afford to fail in this mission.’
FIP has launched a Workforce Development Hub, with two Australians in its leadership team Kirstie Galbraith will focus on advanced practice and specialisation under the project, while Ian Larson will …
Event planning
Check out AJP’s events page for all the latest in news about upcoming pharmacy events Do you find it hard to keep track of the events you’re thinking of attending? …
Seniors noncompliant, study finds
Older Australians aren’t taking their statins consistently, new research has found Researchers from Monash University examined 22,340 adults aged 65 and over who started taking statins between 2014 and 2015. …
Let us help
As the Victorian election draws nearer, pharmacy groups are lobbying to let pharmacists help more with issues like opioids and immunisation The PSA and SHPA have both issued statements outlining …